RxDoctor Payments DataLook up a doctor →

Jihn Han, MD

Clinical Cardiac Electrophysiology · Ypsilanti, MINPI 1033186564

Payments from drug & device makers

$542,855in general payments, 2019–2025

Across 957 payments — averaging $567.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$272K
  • Biosense Webster, Inc.$77K
  • Biotronik Inc.$76K
  • Boston Scientific$54K
  • Abbott$40K
  • Impulse Dynamics (USA) Inc.$21K
  • plus $3K from 16 others
$3,249in research payments, 2019–2025

Across 27 payments — averaging $120.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biotronik Inc.$3K

What the payments were for

  • Travel & lodging$7,89738%
  • Food & beverage$12,75961%
  • Education$1471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$542,855 in reported general payments places this provider in the 95th percentile of 105 clinical cardiac electrophysiology providers in Michigan.

See all clinical cardiac electrophysiology providers in Michigan

Medicare billing

Part B allowed, 2024
$250,941
Medicare patients
1,701
Services billed
2,926

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban780$999,635
XareltoRivaroxaban264$303,751
EntrestoSacubitril/Valsartan25$38,904
JardianceEmpagliflozin15$18,340
FarxigaDapagliflozin Propanediol15$15,474
Metoprolol Succinate465$9,731
Diltiazem 24hr Er (Cd)Diltiazem Hcl166$5,514
Flecainide Acetate65$5,235
Amiodarone Hcl140$3,802
Propafenone Hcl ErPropafenone Hcl19$3,637
Atorvastatin Calcium182$3,385
Dofetilide15$1,772
Metoprolol Tartrate163$1,733
ClopidogrelClopidogrel Bisulfate76$1,326
Carvedilol77$1,254

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$80$303,751264 claims
NovartisEntresto$23$38,90425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 105 clinical cardiac electrophysiology providers in Michigan.

Other clinical cardiac electrophysiology in Ypsilanti

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →